Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structural features enable strong binding interactions with specific enzyme active sites, making it valuable in drug discovery programs focused on oncology. The compound's fluorinated and sulfonamide groups enhance metabolic stability and bioavailability in lead optimization stages. It is also employed in preclinical research to study structure-activity relationships (SAR) for improving potency and selectivity of new therapeutic candidates.